<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR132">
 <label>132.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Priddy</surname>
    <given-names>FH</given-names>
   </name>
   <name>
    <surname>Lewis</surname>
    <given-names>DJM</given-names>
   </name>
   <name>
    <surname>Gelderblom</surname>
    <given-names>HC</given-names>
   </name>
   <name>
    <surname>Hassanin</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Streatfield</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>LaBranche</surname>
    <given-names>C</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial</article-title>
  <source>Lancet HIV</source>
  <year>2019</year>
  <volume>6</volume>
  <issue>4</issue>
  <fpage>e230</fpage>
  <lpage>e239</lpage>
  <pub-id pub-id-type="doi">10.1016/S2352-3018(19)30003-7</pub-id>
  <?supplied-pmid 30885692?>
  <pub-id pub-id-type="pmid">30885692</pub-id>
 </element-citation>
</ref>
